Medtronic has received US Food and Drug Administration (FDA) clearance for its Assurant cobalt iliac balloon-expandable stent system, designed to treat narrowed iliac arteries.

The approval is supported by the nine-month results from a trial that demonstrated technical, procedural and clinical success with the use of the Assurant stent.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Co-principal investigator William Gray said that the Assurant stent demonstrated good safety and long-term patency in the trial, with some of the lowest rates of nine-month target lesion revascularisation and target vessel revascularisation.

The new Medtronic stent uses a modular design to allow for smooth delivery to iliac artery lesions and conformability to the vessel wall.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact